Naismith RT, Cohen JA, Bar-Or A, Comi G, et al. Concurrent administration of serotonergic antidepressants and ozanimod in participants with relapsing multiple sclerosis from the open-label extension DAYBREAK trial. Mult Scler 2023 Dec 21:13524585231216854. doi: 10.1177/13524585231216854.
PMID: 38130041